2018
Simple interventions to decrease use of chemotherapy in patients at the end of life.
Chiang A, Adelson K, Kapo J, Severino K, Lilenbaum R. Simple interventions to decrease use of chemotherapy in patients at the end of life. Journal Of Clinical Oncology 2018, 36: 181-181. DOI: 10.1200/jco.2018.36.30_suppl.181.Peer-Reviewed Original ResearchDays of lifeCourse of illnessEnd of lifeDay of deathGOC conversationsPrimary oncologistCare centerEarly palliative care referralPalliative care referralUse of chemotherapyPalliative care trainingChemotherapy utilizationCare referralPoor prognosisGOC discussionsCancer patientsUnnecessary treatmentGeneral oncologistsCare conversationsPost interventionPatientsChemotherapyMultidisciplinary teamPatient carePhysicians' skills
2016
Pneumonitis in non-small cell lung cancer (NSCLC) patients treated with programmed death 1 (PD1) axis inhibitors.
Gettinger S, Zhang X, Homer R, Possick J, Wurtz A, Goldberg S, Chiang A, Herbst R, Rubinowitz A. Pneumonitis in non-small cell lung cancer (NSCLC) patients treated with programmed death 1 (PD1) axis inhibitors. Journal Of Clinical Oncology 2016, 34: 9030-9030. DOI: 10.1200/jco.2016.34.15_suppl.9030.Peer-Reviewed Original Research
2014
Characterization of aggressive interventions within 30 days of death in lung cancer patients at Smilow Cancer Hospital (SCH).
Zhang B, Adelson K, Velji S, Rimar J, Longley P, Keane B, Chiang A, Lilenbaum R. Characterization of aggressive interventions within 30 days of death in lung cancer patients at Smilow Cancer Hospital (SCH). Journal Of Clinical Oncology 2014, 32: 20-20. DOI: 10.1200/jco.2014.32.30_suppl.20.Peer-Reviewed Original ResearchSmilow Cancer HospitalLung cancer patientsAggressive interventionRothman IndexDay of deathCancer patientsAdvanced cancerClinical conditionsAdvanced lung cancer patientsAdvanced lung cancerPalliative care consultationRetrospective chart reviewPatient's clinical conditionICU stayIOM guidelinesAggressive careChart reviewCancer HospitalCare consultationsCancer populationLung cancerFiscal year 2012Study populationEMR toolStage III